Benzinga's Top #PreMarket Gainers

Brainstorm Cell Therapeutics Inc.BCLI shares jumped 46.85% to $6.99 in pre-market trading ahead of January 5 conference call to discuss final results of Phase 2a trial of NurOwn in ALS. Regulus Therapeutics Inc. RGLS shares jumped 6.54% to $17.10 in pre-market trading. Regulus Therapeutics shares have jumped 117.94% over the past 52 weeks, while the S&P 500 index has gained 12.39% in the same period. Arrowhead Research Corp ARWR shares rose 4.34% to $7.70 in pre-market trading after dropping 2.51% on Wednesday. NeuroDerm Ltd.NDRM shares gained 3.63% to $14.55 in the pre-market trading session after tumbling 22.60% on Wednesday. Kite Pharma, Inc. KITE shares surged 3.17% to $59.50 in pre-market trading. Credit Suisse reiterated an Outperform rating on Kite Pharma and raised the price target from $34.00 to $71.00.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPre-Market OutlookMarketsMoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!